Earth’s Energy Limited reports progress on South Australian geothermal projects with promising feasibility study results, while navigating executive transitions and shareholder governance challenges.
Anatara Lifesciences reports mixed results from its Phase II GaRP-IBS trial, missing the primary efficacy target but showing significant improvements in anxiety and patient-reported relief, while advancing its anti-obesity pre-clinical program.
